🇺🇸 FDA
Patent

US 9359285

Androgen receptor modulator compounds and methods

granted A61PA61P1/14A61P15/08

Quick answer

US patent 9359285 (Androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/14, A61P15/08, A61P15/10, A61P15/16